Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003
What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
A Diagnostic Index of Active Demyelination:Myelin Basic Protein in Cerebrospinal Fluid
Ann Neurol 8:25-31, Cohen,S.R.,et al, 1980
Radioimmunoassay of Myelin Basic Protein in Spinal Fluid:An Index of Active Demyelination
NEJM 295:1455, Cohen,S.R.,et al, 1976